Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
46
ICUI Quote, Financials, Valuation and Earnings
Last price:
$152.81
Seasonality move
:
4.36%
Day range:
$149.05 - $153.11
52-week range:
$107.00 - $175.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.62x
P/B ratio:
1.78x
Volume:
168.5K
Avg. volume:
210.1K
1-year change:
-4.97%
Market cap:
$3.8B
Revenue:
$2.4B
EPS (TTM):
-$0.31
Analysts' Opinion
-
Consensus RatingICU Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $180.83, ICU Medical, Inc. has an estimated upside of 18.2% from its current price of $152.99.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $172.00 representing 100% downside risk from its current price of $152.99.
Fair Value
-
According to the consensus of 4 analysts, ICU Medical, Inc. has 18.2% upside to fair value with a price target of $180.83 per share.
ICUI vs. S&P 500
-
Over the past 5 trading days, ICU Medical, Inc. has overperformed the S&P 500 by 8.73% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ICU Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ICU Medical, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter ICU Medical, Inc. reported revenues of $537.7M.
Earnings Growth
-
ICU Medical, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter ICU Medical, Inc. reported earnings per share of -$0.14.
Enterprise value:
4.9B
EV / Invested capital:
--
Price / LTM sales:
1.62x
EV / EBIT:
37.72x
EV / Revenue:
2.09x
PEG ratio (5yr expected):
-0.59x
EV / Free cash flow:
78.04x
Price / Operating cash flow:
60.49x
Enterprise value / EBITDA:
14.64x
Gross Profit (TTM):
$845.8M
Return On Assets:
-0.18%
Net Income Margin (TTM):
-0.32%
Return On Equity:
-0.36%
Return On Invested Capital:
-0.21%
Operating Margin:
5.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.2B | $2.3B | $2.3B | $588.4M | $537.7M | |
| Gross Profit | $715.4M | $751.8M | $845.8M | $205M | $202.3M | |
| Operating Income | $51.4M | $28.6M | $128.8M | $21.2M | $28.3M | |
| EBITDA | $512.6M | $257.6M | $331.7M | $76.9M | $79.1M | |
| Diluted EPS | -$1.17 | -$4.57 | -$0.31 | -$1.35 | -$0.14 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Total Assets | $1.8B | $4.5B | $4.4B | $4.3B | $4.1B | |
| Current Liabilities | $185.1M | $489M | $464M | $549.6M | $492.9M | |
| Total Liabilities | $249.4M | $2.4B | $2.3B | $2.3B | $2B | |
| Total Equity | $1.6B | $2B | $2.1B | $2B | $2.1B | |
| Total Debt | $38.2M | $1.7B | $1.7B | $1.6B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $73.2M | $255.1M | $159.4M | $36.1M | $56.7M | |
| Cash From Investing | -$81.3M | -$93.1M | $114.1M | -$22.9M | -$30M | |
| Cash From Financing | -$38.5M | -$55.5M | -$285.2M | -$10.4M | -$25.7M | |
| Free Cash Flow | -$12.5M | $159.5M | $62.2M | $13.2M | $25M | |
ICUI
Sector
Market Cap
$3.8B
$28.3M
Price % of 52-Week High
87.17%
51.99%
Dividend Yield
0%
0%
Shareholder Yield
2.05%
-1.59%
1-Year Price Total Return
-4.97%
-17.41%
Beta (5-Year)
0.799
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$148.05
200-day SMA
Buy
Level
$132.80
Bollinger Bands (100)
Buy
Level
121.22 - 144.04
Chaikin Money Flow
Buy
Level
8.8M
20-day SMA
Buy
Level
$147.56
Relative Strength Index (RSI14)
Buy
Level
63.20
ADX Line
Buy
Level
15.23
Williams %R
Sell
Level
-8.739
50-day SMA
Buy
Level
$141.10
MACD (12, 26)
Buy
Level
2.42
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
33M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1397)
Buy
CA Score
(Annual)
Level (-0.257)
Buy
Beneish M-Score
(Annual)
Level (-2.8084)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.4622)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Stock Forecast FAQ
In the current month, ICUI has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ICUI average analyst price target in the past 3 months is $180.83.
-
Where Will ICU Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that ICU Medical, Inc. share price will rise to $180.83 per share over the next 12 months.
-
What Do Analysts Say About ICU Medical, Inc.?
Analysts are divided on their view about ICU Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ICU Medical, Inc. is a Sell and believe this share price will drop from its current level to $172.00.
-
What Is ICU Medical, Inc.'s Price Target?
The price target for ICU Medical, Inc. over the next 1-year time period is forecast to be $180.83 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ICUI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ICU Medical, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ICUI?
You can purchase shares of ICU Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ICU Medical, Inc. shares.
-
What Is The ICU Medical, Inc. Share Price Today?
ICU Medical, Inc. was last trading at $152.81 per share. This represents the most recent stock quote for ICU Medical, Inc.. Yesterday, ICU Medical, Inc. closed at $152.99 per share.
-
How To Buy ICU Medical, Inc. Stock Online?
In order to purchase ICU Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ICUI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ICUI
Sector
P/E ratio
--
24.24x
PEG ratio
-0.59x
-0.01x
P/B ratio
1.78x
1.84x
Price / LTM sales
1.62x
1.60x
Growth Metrics
ICUI
Sector
Revenue growth
-8.61%
4.6%
Earnings growth
89.81%
10.71%
Revenue (5-year growth)
13.44%
6.45%
Earnings forecast
$1.69
-$0.19
Profitability
ICUI
Sector
Profitability FY 2024
$821.7M
$3.5M
Return on invested capital
-0.21%
-32.04%
Return on assets
-0.18%
-28.44%
Return on equity
-0.36%
-38.09%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
ICUI
Sector
Total cash
$299.7M
$26.1M
Short term investments
--
$25.7M
Total assets
$4.2B
$76.4M
Long term debt
$1.4B
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
